
Balazs Halmos
@BalazsHalmosMD
Followers
9K
Following
21K
Media
4K
Statuses
8K
Thoracic/precision oncology 🇭🇺🇺🇸
Ridgefield, CT
Joined June 2019
My heart sank very low today as a cancer care provider working at an institution caring for a very large number of Medicaid recipients. It is already extremely hard to face a devastating cancer diagnosis- just can’t imagine what not having a safety net to at least be able to.
The House just passed a bill that makes the biggest cut to #Medicaid in history & kicks millions off health coverage. This will have a lasting impact on the fight against cancer. Health care costs will ⬆️& those who need screening/preventive care could have to go without. (1/2).
5
19
75
As tomorrow is 1st day of hem/onc fellowship for many- thought i’d reshare this little piece as to what i would tell myself if i were starting fellowship now (which sounds attractive… all that black hair …).☑️Stay curious.☑️Remain humble.☑️Be positive.☑️Build and enjoy your.
What could i tell to my younger self on the interview trail?.You will need to read this short piece in @OncNewsCentral to find out!.@HemOncFellows
0
6
43
Wow!!. What an amazing demonstration of the fantastic gains of the last 2 decades!. Tremendous benefits of targeted/immunotherapy (+LC screening, mol path/biomarkers, innovative pulm/surg/xrt, pt advocacy etc). And patients diagnosed today can expect even better outcomes given
Clear survival gains in treating lung cancer reflected in this @NEJM article. All pts with lung cancer treated in public hospitals in France show median survival improved from 8.5 months in 2000 to 20.7 months in 2020. No room for nihilism anymore!.
0
6
35
DatoDxd Making ADCs Great Again?. Based on TROPION Lung01/05 pooled data for advanced prev treated EGFR mutated NSCLC.☑️With ORR>40%.☑️reasonable DOR.☑️notable but generally manageable safety profile w mucositis/ILD/dry eyes as main concerns.FDA says yes to Dato.I say: Ditto!
Datopotamab deruxtecan (DatoDXd - Trop2 ADC) now @FDAOncology approved off #TROPIONLung01 & 05 for previously treated mEGFR NSCLC . - ORR of 42.7%, mDoR 7.0 mos .- mPFS: 5.8 mos and mOS 15.6 mos.- AEs: Nausea, stomatitis, and ILD. #lcsm #OncTwitter @US_FDA
0
4
31
What an amazing evening each year celebrating our @MontefioreNYC graduating hem/onc fellows!. Particularly special this year with 2 of them moving on to very special thor onc adventures:.@HyeinJeon_MD to MedStar/Georgetown- @StephenVLiu .and Shuai Wang to Vanderbilt
3
4
40